Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
World J Emerg Surg ; 18(1): 7, 2023 01 18.
Artículo en Inglés | MEDLINE | ID: mdl-36653865

RESUMEN

BACKGROUND: Frailty is associated with poor post-operative outcomes in emergency surgical patients. Shared multidisciplinary models have been developed to provide a holistic, reactive model of care to improve outcomes for older people living with frailty. We aimed to describe current perioperative practices, and surgeons' awareness and perception of perioperative frailty management, and barriers to its implementation. METHODS: A qualitative cross-sectional survey was sent via the World Society of Emergency Surgery e-letter to their members. Responses were analysed using descriptive statistics and reported by themes: risk scoring systems, frailty awareness and assessment and barriers to implementation. RESULT: Of 168/1000 respondents, 38% were aware of the terms "Perioperative medicine for older people undergoing surgery" (POPS) and Comprehensive Geriatric Assessment (CGA). 66.6% of respondents assessed perioperative risk, with 45.2% using the American Society of Anaesthesiologists Physical Status Classification System (ASA-PS). 77.8% of respondents mostly agreed or agreed with the statement that they routinely conducted medical comorbidity management, and pain and falls risk assessment during emergency surgical admissions. Although 98.2% of respondents agreed that frailty was important, only 2.4% performed CGA and 1.2% used a specific frailty screening tool. Clinical frailty score was the most commonly used tool by those who did. Screening was usually conducted by surgical trainees. Key barriers included a lack of knowledge about frailty assessment, a lack of clarity on who should be responsible for frailty screening, and a lack of trained staff. CONCLUSIONS: Our study highlights the ubiquitous lack of awareness regarding frailty assessment and the POPS model of care. More training and clear guidelines on frailty scoring, alongside support by multidisciplinary teams, may reduce the burden on surgical trainees, potentially improving rates of appropriate frailty assessment and management of the frailty syndrome in emergency surgical patients.


Asunto(s)
Fragilidad , Cirujanos , Humanos , Anciano , Fragilidad/diagnóstico , Anciano Frágil , Estudios Transversales , Medición de Riesgo
2.
J Hepatol ; 41(4): 599-605, 2004 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-15464240

RESUMEN

BACKGROUND/AIMS: The use of cell lines in bioartificial liver support systems (BALSS) to treat fulminant hepatic failure (FHF) is hindered by their reduced metabolic functions, which could be further decreased by the patient's serum/plasma. Hence, the aim of this study was to (i) test the effect of the FHF serum on C3A cell metabolism; (ii) precondition the cells to improve their metabolic capacity. METHODS: C3A cells were preconditioned in a medium developed at the University of Edinburgh (UoE) or a 10% FHF serum medium. Metabolism capacity was assessed on days 3, 7 and 10 and compared with primary porcine hepatocytes. Preconditioned-cell metabolism was reassessed after (i) passage and (ii) incubation with 10% FHF serum. RESULTS: UoE-preconditioned cells showed time-dependent increase in gluconeogenesis (500%), ureogenesis (200%), galactose elimination (240%) albumin synthesis (250%). These results were in the same order of magnitude as the ones obtained with primary porcine hepatocytes and were further enhanced by cell passage. UoE-preconditioning prevented the decrease of metabolism induced by acute incubation with FHF serum on control C3A cells. Preconditioning with FHF serum did not improve cell metabolism. CONCLUSIONS: Cell preconditioning with UoE-medium increases metabolic capacity and would greatly improve BALSS efficacy.


Asunto(s)
Hepatoblastoma/metabolismo , Fallo Hepático Agudo/sangre , Neoplasias Hepáticas/metabolismo , Hígado Artificial , Albúminas/biosíntesis , Animales , Línea Celular Tumoral , Células Cultivadas , Medios de Cultivo/farmacología , Galactosa/metabolismo , Gluconeogénesis , Hepatoblastoma/patología , Hepatocitos/metabolismo , Humanos , Neoplasias Hepáticas/patología , Porcinos , Factores de Tiempo , Urea/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...